ABSTRACT

The use of vaccines has considerably improved worldwide public health by preventing and controlling infectious disease. The development of vaccinations has advanced significantly over the years, resulting in the discovery and production of numerous safe and efficient vaccines. This abstract describes recent developments in vaccine research and development and emphasizes significant factors that have influenced the development of contemporary vaccines. In order to fulfill the problems outlined by COVID-19, the present research set out to analyze the procedures utilized by two significant worldwide regulating bodies for pharmaceutical organizations to approve vaccines and to create a roadmap for vaccine advancement in developing countries. Methods: This article provides a brief update on the regulatory clearance processes participating in the registration of vaccines in the throughout the United States of America (USA) and the EU, or the European Union. The comparative analysis aids in elucidating the regulatory issues that surface during the corresponding vaccination authorization processes in both in the EU and the USA. In conclusion, this paper offers a thorough account of recent developments in vaccine development, illuminating the growth of both conventional and cutting- edge platforms and their contributions to the fight against infectious diseases. Additionally, emphasize the significance of continued studies and cooperation in order to face problems in vaccine development and international health security. Keywords: Marketing authorization (MA), Vaccine, COVID-19
Publication date: 01/09/2024

https://ijbpas.com/pdf/2024/September/MS_IJBPAS_2024_8301.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.9.8301